Authors:
HELTON DR
TIZZANO JP
MONN JA
SCHOEPP DD
KALLMAN MJ
Citation: Dr. Helton et al., ANXIOLYTIC AND SIDE-EFFECT PROFILE OF LY354740 - A POTENT, HIGHLY SELECTIVE, ORALLY-ACTIVE AGONIST FOR GROUP-II METABOTROPIC GLUTAMATE RECEPTORS, The Journal of pharmacology and experimental therapeutics, 284(2), 1998, pp. 651-660
Authors:
ORNSTEIN PL
BLEISCH TJ
ARNOLD MB
KENNEDY JH
WRIGHT RA
JOHNSON BG
TIZZANO JP
HELTON DR
KALLMAN MJ
SCHOEPP DD
HERIN M
Citation: Pl. Ornstein et al., 2-SUBSTITUTED MINO-2-((1SR,2SR)-2-CARBOXYCYCLOPROP-1-YL)GLYCINES AS POTENT AND SELECTIVE ANTAGONISTS OF GROUP-II METABOTROPIC GLUTAMATE RECEPTORS - 2 - EFFECTS OF AROMATIC-SUBSTITUTION, PHARMACOLOGICAL CHARACTERIZATION, AND BIOAVAILABILITY, Journal of medicinal chemistry, 41(3), 1998, pp. 358-378
Citation: Dr. Helton et al., CLONIDINE ATTENUATES INCREASES IN SENSORIMOTOR REACTIVITY RESULTING FROM WITHDRAWAL OF CHRONIC NICOTINE, Addiction, 92(5), 1997, pp. 626-626
Citation: K. Rasmussen et al., SEROTONIN-1A ANTAGONISTS ATTENUATE THE EFFECTS OF NICOTINE WITHDRAWALON THE AUDITORY STARTLE RESPONSE, Synapse, 27(2), 1997, pp. 145-152
Authors:
HELTON DR
TIZZANO JP
MONN JA
SCHOEPP DD
KALLMAN MJ
Citation: Dr. Helton et al., LY354740 - A METABOTROPIC GLUTAMATE-RECEPTOR AGONIST WHICH AMELIORATES SYMPTOMS OF NICOTINE WITHDRAWAL IN RATS, Neuropharmacology, 36(11-12), 1997, pp. 1511-1516
Authors:
IYENGAR S
HIPSKIND PA
GEHLERT DR
SCHOBER D
LOBB KL
NIXON JA
HELTON DR
KALLMAN MJ
BOUCHER S
COUTURE R
LI DL
SIMMONS RMA
Citation: S. Iyengar et al., LY303870, A CENTRALLY ACTIVE NEUROKININ-1 ANTAGONIST WITH A LONG-DURATION OF ACTION, The Journal of pharmacology and experimental therapeutics, 280(2), 1997, pp. 774-785
Authors:
MONN JA
VALLI MJ
MASSEY SM
WRIGHT RA
SALHOFF CR
JOHNSON BG
HOWE T
ALT CA
RHODES GA
ROBEY RL
GRIFFEY KR
TIZZANO JP
KALLMAN MJ
HELTON DR
SCHOEPP DD
Citation: Ja. Monn et al., DESIGN, SYNTHESIS, AND PHARMACOLOGICAL CHARACTERIZATION OF (-2-AMINOBICYCLO[3.1.0]HEXANE-2,6-DICARBOXYLIC ACID (LY354740) - A POTENT, SELECTIVE, AND ORALLY-ACTIVE GROUP-2 METABOTROPIC GLUTAMATE-RECEPTOR AGONIST POSSESSING ANTICONVULSANT AND ANXIOLYTIC PROPERTIES()), Journal of medicinal chemistry, 40(4), 1997, pp. 528-537
Authors:
HELTON DR
KALLMAN MJ
JOHNSON JA
TIZZANO JP
Citation: Dr. Helton et al., TIME-DEPENDENT EFFECTS OF NICOTINE ADMINISTRATION AND CESSATION ON COGNITIVE PERFORMANCE, Addiction, 91(1), 1996, pp. 140-140
Authors:
RASMUSSEN K
CZACHURA JF
KALLMAN MJ
HELTON DR
Citation: K. Rasmussen et al., THE CCK-B ANTAGONIST LY288513 BLOCKS THE EFFECTS OF NICOTINE WITHDRAWAL ON AUDITORY STARTLE, NeuroReport, 7(5), 1996, pp. 1050-1052
Authors:
HELTON DR
BERGER JE
CZACHURA JF
RASMUSSEN K
KALLMAN MJ
Citation: Dr. Helton et al., CENTRAL-NERVOUS-SYSTEM CHARACTERIZATION OF THE NEW CHOLECYSTOKININ, ANTAGONIST LY288513, Pharmacology, biochemistry and behavior, 53(3), 1996, pp. 493-502
Authors:
TIZZANO JP
GRIFFEY KI
VALLI MJ
HELTON DR
KALLMAN MJ
SCHOEPP DD
MONN JA
Citation: Jp. Tizzano et al., INTRACEREBRAL INJECTIONS OF METABOTROPIC GLUTAMATE-RECEPTOR AGONISTS CAN INDUCE OR PROTECT AGAINST LIMBIC SEIZURES IN MICE, Behavioural pharmacology, 6(5-6), 1995, pp. 633-634
Citation: Dr. Helton et We. Colbert, ALTERATIONS OF IN-VITRO 5-HT RECEPTOR PHARMACOLOGY AS A FUNCTION OF MULTIPLE TREATMENT WITH 5-HYDROXYTRYPTAMINE OR 8-HYDROXY-2-(DI-N-PROPYLAMINO) TETRALIN IN RAT ISOLATED AORTA, UTERUS AND FUNDUS, AND GUINEA-PIG ISOLATED TRACHEA, Journal of Pharmacy and Pharmacology, 46(11), 1994, pp. 902-905
Authors:
HELTON DR
MODLIN DL
TIZZANO JP
RASMUSSEN K
Citation: Dr. Helton et al., NICOTINE WITHDRAWAL - A BEHAVIORAL-ASSESSMENT USING SCHEDULE-CONTROLLED RESPONDING, LOCOMOTOR-ACTIVITY, AND SENSORIMOTOR REACTIVITY, Psychopharmacology, 113(2), 1993, pp. 205-210
Authors:
RASMUSSEN K
HELTON DR
BERGER JE
SCEARCE E
Citation: K. Rasmussen et al., THE CCK-B ANTAGONIST LY288513 BLOCKS EFFECTS OF DIAZEPAM WITHDRAWAL ON AUDITORY STARTLE, NeuroReport, 5(2), 1993, pp. 154-156
Authors:
TIZZANO JP
GRIFFEY KI
JOHNSON JA
FIX AS
HELTON DR
SCHOEPP DD
Citation: Jp. Tizzano et al., INTRACEREBRAL 1S,3R-1-AMINOCYCLOPENTANE-1,3-DICARBOXYLIC ACID (1S,3R-ACPD) PRODUCES LIMBIC SEIZURES THAT ARE NOT BLOCKED BY IONOTROPIC GLUTAMATE-RECEPTOR ANTAGONISTS, Neuroscience letters, 162(1-2), 1993, pp. 12-16